Meta facebook tracking pixel

Listen Now

Topics Covered

  • Overview of Blood Cancers, in the Context of COVID-19
  • New Research Presented at ASH
  • Disease-Specific Treatment Updates from ASH on:
    • Lymphoma
    • Multiple Myeloma
    • Leukemia
    • Myeloproliferative Disorders
  • The Role of Precision Medicine & Clinical Trials
  • The Increasing Role of Telemedicine/Telehealth Appointments
  • Guidelines to Prepare for These Appointments to Increase Their Benefits, including Technology, List of Questions & Discussion of OpenNotes
  • Key Questions to Ask Your Healthcare Team about Quality-of-Life Concerns & Goal of Care
  • Questions for Our Panel of Experts

Our Panel of Experts

Presenter

Peter Martin, MD, MS

Chief, Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital

Presenter

Matthew J. Butler, MD

Assistant Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Mays MD Anderson Cancer Center, UT Health San Antonio

Presenter

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Presenter

Ruben A. Mesa, MD, FACP

Executive Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, Mays Cancer Center – An NCI Designated Cancer Center

Presenter

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop Download button

Workshop Date

This workshop was originally recorded on December 16, 2021.

Search by:

Diagnosis

Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top

Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you can read more about our use of cookies which help us make continuous improvements to our website. Privacy Policy.